CURE.AX vs. HGEN.AX

Last updated Jul 18, 2026

CURE.AX (Global X S&P Biotech ETF) and HGEN.AX (Global X Hydrogen ETF) are both exchange-traded funds - CURE.AX is a Health & Biotech Equities fund tracking the S&P Biotechnology Select Industry Index, while HGEN.AX is a Global Equities fund tracking the Global X Hydrogen Index. Both are passively managed. Over the past 3 years, CURE.AX returned 19.53%/yr vs 9.56%/yr for HGEN.AX. At a 0.41 correlation, their price movements are largely independent.

Performance

CURE.AX vs. HGEN.AX - Performance Comparison

The chart below illustrates the hypothetical performance of a A$10,000 investment in Global X S&P Biotech ETF (CURE.AX) and Global X Hydrogen ETF (HGEN.AX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, CURE.AX achieves a 17.74% return, which is significantly lower than HGEN.AX's 34.18% return.

CURE.AX

• 1D: -4.01%
• 1M: 11.45%
• 6M: 14.56%
• YTD: 17.74%
• 1Y: 57.67%
• 3Y*: 19.53%
• 5Y*: 4.76%
• 10Y*: —

HGEN.AX

• 1D: -6.71%
• 1M: -22.55%
• 6M: 6.70%
• YTD: 34.18%
• 1Y: 81.42%
• 3Y*: 9.56%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

CURE.AX vs. HGEN.AX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
CURE.AX Global X S&P Biotech ETF	17.74%	25.25%	8.13%	10.63%	-22.98%	-8.10%
HGEN.AX Global X Hydrogen ETF	34.18%	43.64%	-10.40%	-20.10%	-36.18%	7.90%

Correlation

The correlation between CURE.AX and HGEN.AX is 0.20, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.20
Correlation (3Y) Calculated over the trailing 3-year period	0.34
Correlation (All Time) Calculated using the full available price history since Oct 6, 2021	0.41

Over the past year, the correlation between CURE.AX and HGEN.AX has dropped to 0.20 - well below their long-term average of 0.41, suggesting their price drivers have been diverging.

Return for Risk

CURE.AX vs. HGEN.AX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CURE.AX

CURE.AX Risk / Return Rank: 85
CURE.AX Sharpe Ratio Rank: 87
CURE.AX Sortino Ratio Rank: 84
CURE.AX Omega Ratio Rank: 80
CURE.AX Calmar Ratio Rank: 93
CURE.AX Martin Ratio Rank: 82

HGEN.AX

HGEN.AX Risk / Return Rank: 66
HGEN.AX Sharpe Ratio Rank: 69
HGEN.AX Sortino Ratio Rank: 64
HGEN.AX Omega Ratio Rank: 61
HGEN.AX Calmar Ratio Rank: 73
HGEN.AX Martin Ratio Rank: 63

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CURE.AX vs. HGEN.AX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Global X S&P Biotech ETF (CURE.AX) and Global X Hydrogen ETF (HGEN.AX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	CURE.AX	HGEN.AX	Difference
Sharpe ratio: Return per unit of total volatility	2.15	1.67	+0.48
Sortino ratio: Return per unit of downside risk	2.91	2.24	+0.66
Omega ratio: Gain probability vs. loss probability	1.36	1.28	+0.08
Calmar ratio: Return relative to maximum drawdown	4.77	2.71	+2.06
Martin ratio: Return relative to average drawdown	11.94	8.25	+3.69

CURE.AX vs. HGEN.AX - Sharpe Ratio Comparison

The current CURE.AX Sharpe Ratio is 2.15, which is comparable to the HGEN.AX Sharpe Ratio of 1.67. The chart below compares the historical Sharpe Ratios of CURE.AX and HGEN.AX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

CURE.AX vs. HGEN.AX - Drawdown Comparison

The maximum CURE.AX drawdown since its inception was -59.81%, smaller than the maximum HGEN.AX drawdown of -72.54%. Use the drawdown chart below to compare losses from any high point for CURE.AX and HGEN.AX.

Drawdown Indicators

	CURE.AX	HGEN.AX	Difference
Max Drawdown Largest peak-to-trough decline	-59.81%	-72.54%	+12.73%
Max Drawdown (1Y) Largest decline over 1 year	-11.68%	-29.11%	+17.43%
Max Drawdown (3Y) Largest decline over 3 years	-28.37%	-49.84%	+21.47%
Max Drawdown (5Y) Largest decline over 5 years	-50.92%	—	—
Current Drawdown Current decline from peak	-9.24%	-30.24%	+21.00%
Average Drawdown Average peak-to-trough decline	-27.37%	-47.61%	+20.24%
Ulcer Index Depth and duration of drawdowns from previous peaks	4.69%	9.68%	-4.99%

Volatility

CURE.AX vs. HGEN.AX - Volatility Comparison

The current volatility for Global X S&P Biotech ETF (CURE.AX) is 10.25%, while Global X Hydrogen ETF (HGEN.AX) has a volatility of 14.51%. This indicates that CURE.AX experiences smaller price fluctuations and is considered to be less risky than HGEN.AX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	CURE.AX	HGEN.AX	Difference
Volatility (1M) Calculated over the trailing 1-month period	10.25%	14.51%	-4.26%
Volatility (6M) Calculated over the trailing 6-month period	21.40%	33.68%	-12.28%
Volatility (1Y) Calculated over the trailing 1-year period	26.14%	47.24%	-21.10%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	30.95%	36.75%	-5.80%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	31.73%	36.75%	-5.02%

Dividends

CURE.AX vs. HGEN.AX - Dividend Comparison

CURE.AX has not paid dividends to shareholders, while HGEN.AX's dividend yield for the trailing twelve months is around 0.83%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019
CURE.AX Global X S&P Biotech ETF	0.00%	0.00%	0.00%	0.00%	0.06%	11.64%	9.47%	2.05%
HGEN.AX Global X Hydrogen ETF	0.83%	0.34%	0.60%	0.17%	0.09%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both CURE.AX and HGEN.AX in my portfolio?

CURE.AX and HGEN.AX have a correlation of 0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

What is the main difference between CURE.AX and HGEN.AX?

CURE.AX is categorized as Health & Biotech Equities, while HGEN.AX is Global Equities. CURE.AX tracks S&P Biotechnology Select Industry Index, while HGEN.AX tracks Global X Hydrogen Index.